View in EDS HTML Full Text PDF Full Text

Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia.

Saved in:
Bibliographic Details
Title: Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia.
Authors: Liu, Ge1 (AUTHOR), Liang, Taotao1 (AUTHOR), Ai, Hao1 (AUTHOR), Wang, Shan1 (AUTHOR), Yin, Songke1 (AUTHOR), Wang, Xiaojiao1,2 (AUTHOR), Wu, Hongfei1 (AUTHOR), Wang, Qian1 (AUTHOR), Zhao, Hongmian3 (AUTHOR), Liu, Xiaojuan4 (AUTHOR), Luv, Xiaodong1 (AUTHOR), Liu, Jia1 (AUTHOR), Yin, Qingsong1 (AUTHOR) jnyinqingsong@163.com
Source: Communications Biology. 5/8/2026, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23993642
DOI:10.1038/s42003-026-10201-3